2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017-11-13
SCID: 54.1/mhq7uj2m
Discuss with AI
2017 ACC/AHA GuidelineClass of Recommendation and Level of Evidence (COR/LOE)guideline-directed management and therapy (GDMT)hypertension management in adultssystematic evidence review / Evidence Review Committee (ERC)
Figures from the paper
Abstract (AI)
Since 1980, the American College of Cardiology (ACC) and American Heart Association (AHA) have translated scientific evidence into clinical practice guidelines (guidelines) with recommendations to improve cardiovascular health.In 2013, the National Heart, Lung, and Blood Institute (NHLBI) Advisory Council recommended that the NHLBI focus specifically on reviewing the highest-quality evidence and partner with other organizations to develop recommendations.P-1,P-2 Accordingly, the ACC and AHA collaborated with the NHLBI and stakeholder and professional organizations to complete and publish 4 guidelines (on assessment of cardiovascular risk, lifestyle modifications to reduce cardiovascular risk, management of blood cholesterol in adults, and management of overweight and obesity in adults) to make them available to the widest possible constituency.In 2014, the ACC and AHA, in partnership with several other professional societies, initiated a guideline on the prevention, detection, evaluation, and management of high blood pressure (BP) in adults.Under the management of the ACC/ AHA Task Force, a Prevention Subcommittee was appointed to help guide development of the suite of guidelines on prevention of cardiovascular disease (CVD).These guidelines, which are based on systematic methods to evaluate and classify evidence, provide a cornerstone for quality cardiovascular care.The ACC and AHA sponsor the development and publication of guidelines without commercial support, and members of each organization volunteer their time to the writing and review efforts.Guidelines are official policy of the ACC and AHA. HypertensionJune 2018of clinical practice.The Task Force may also invite organizations and professional societies with related interests and expertise to participate as partners, collaborators, or endorsers. Relationships With Industry and Other EntitiesThe ACC and AHA have rigorous policies and methods to ensure that guidelines are developed without bias or improper influence.The complete relationships with industry and other entities (RWI) policy can be found online.Appendix 1 of the present document lists writing committee members' relevant RWI.For the purposes of full transparency, writing committee members' comprehensive disclosure information is available online.Comprehensive disclosure information for the Task Force is available online. Evidence Review and Evidence Review CommitteesIn developing recommendations, the writing committee uses evidence-based methodologies that are based on all available data.P-6-P-9 Literature searches focus on randomized controlled trials (RCTs) but also include registries, nonrandomized comparative and descriptive studies, case series, cohort studies, systematic reviews, and expert opinion.Only key references are cited.An independent evidence review committee (ERC) is commissioned when there are 1 or more questions deemed of utmost clinical importance that merit formal systematic review.The systematic review will determine which patients are most likely to benefit from a drug, device, or treatment strategy and to what degree.Criteria for commissioning an ERC and formal systematic review include: a) the absence of a current authoritative systematic review, b) the feasibility of defining the benefit and risk in a time frame consistent with the writing of a guideline, c) the relevance to a substantial number of patients, and d) the likelihood that the findings can be translated into actionable recommendations.ERC members may include methodologists, epidemiologists, healthcare providers, and biostatisticians.The recommendations developed by the writing committee on the basis of the systematic review are marked with "SR." Guideline-Directed Management and TherapyThe term guideline-directed management and therapy (GDMT) encompasses clinical evaluation, diagnostic testing, and pharmacological and procedural treatments.For these and all recommended drug treatment regimens, the reader should confirm the dosage by reviewing product insert material and evaluate the treatment regimen for contraindications and interactions.The recommendations are limited to drugs, devices, and treatments approved for clinical use in the United States. Class of Recommendation and Level of EvidenceThe Class of Recommendation (COR) indicates the strength of the recommendation, encompassing the estimated magnitude and certainty of benefit in proportion to risk.The Level of Evidence (LOE) rates the quality of scientific evidence that supports the intervention on the basis of the type, quantity, and consistency of data from clinical trials and other sources (Table 1).P-6-P-8
Key Findings
1
ACC/AHA developed 2017 guideline for prevention, detection, evaluation, and management of adult high blood pressure in partnership with multiple professional societies and NHLBI.
2
ACC/AHA guidelines are produced without commercial support, with transparent disclosure of relationships with industry for writing committee and Task Force members.
3
Guidelines are based on systematic evidence-review methods prioritizing randomized controlled trials but including registries, observational studies, and expert opinion.
4
Independent Evidence Review Committees (ERCs) are commissioned when questions of high clinical importance lack authoritative systematic reviews; recommendations based on these are marked “SR.”
5
Recommendations use standardized Class of Recommendation (COR) and Level of Evidence (LOE) frameworks to convey recommendation strength and evidence quality.
Research Object
Prevention, detection, evaluation, and management of high blood pressure (hypertension) in adults
Research Subject
Clinical practice guideline recommendations (including evidence review, classes of recommendation, levels of evidence, and guideline-directed management and therapy) for improving cardiovascular outcomes related to adult hypertension
Publication Details
Publication Date
2017-11-13
Journal
Publisher
ISSN
Cited by
8098
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai13
Bias in meta-analysis detected by a simple, graphical test1997
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials2011
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration2009
2013 ESH/ESC Guidelines for the management of arterial hypertension2013
2013 ACCF/AHA Guideline for the Management of Heart Failure2013
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults2013
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 20152016
Guidelines for the Early Management of Patients With Acute Ischemic Stroke2013
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation2014
A Randomized Trial of Intensive versus Standard Blood-Pressure Control2015
Social Determinants of Risk and Outcomes for Cardiovascular Disease2015
Interventions to Promote Physical Activity and Dietary Lifestyle Changes for Cardiovascular Risk Factor Reduction in Adults2010
Ambulatory Blood-Pressure Monitoring2006
Cited by11
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association2023
Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association2019
Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association2022
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association2024
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy2018
Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension2021
Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association2019
Clinical practice guidelines for the care of girls and women with Turner syndrome2024
Current challenges for hypertension management: From better hypertension diagnosis to improved patients' adherence and blood pressure control2021
Prevalence, awareness, treatment, and control rates of hypertension in the general population of Australia: a systematic review and meta-analysis2024
Neurovascular and Cognitive Dysfunction in Hypertension2019